Pyrido [2,1-a] isoquinoline derivatives
US7122555B2 · kind B2 · utility
20Cited by
7References
24Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 17, 2004 |
| Grant date | Oct 17, 2006 |
| Priority date | — |
| Expiry date | Sep 19, 2024 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/2853
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides compounds of formula (I)wherein R1, R2, R3 and R4 are as indicated in the description, or a pharmaceutically acceptable salt thereof. The compounds are useful for the treatment of diseases which are associated with DPP-IV, such as diabetes, particularly non-insulin dependent diabetes mellitus, and impaired glucose tolerance.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.